Epidemiological Analysis and Geographical Distribution of Patients Suffering from Rheumatoid Arthritis, Eligible for First-Line Therapy/Monotherapy Treatment with Subcutaneous Formulation of Tocilizumab in the Republic of Macedonia

1. Rheumatoid Arthritis: National Clinical Guideline for Management and Treatment in Adults. NICE Clinical Guidelines, No. 79.National Collaborating Centre for Chronic Conditions (UK). London: Royal College of Physicians (UK); 2009 Feb.Search in Google Scholar

2. Aletaha D. et al., Treating rheumatoid arthritis to target: recommendations of an international task force 2010.20215140Search in Google Scholar

3. Gibofsky A. et. al., Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis. Am J Manag Care 2012; 18: S295–302.Search in Google Scholar

4. Alamanos Y. et al., Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review 2010.Search in Google Scholar

5. Andrew P. Cope., Clinical Immunology (Fourth Edition) 2013.Search in Google Scholar

6. Reniero L et al., Study of advanced rheumatoid arthritis 2014.Search in Google Scholar

7. Machold KP et al., Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis, Rheumatology, 2004, vol. 43 (pg. 906–14).10.1093/rheumatology/keh199Search in Google Scholar

8. Lard LR et al. Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies, Am J Med, 2001, vol. 111 (pg. 446–51).10.1016/S0002-9343(01)00872-5Search in Google Scholar

9. Mottonen T et al. Delay to institution of therapy and induction of remission using single-drug or combination-disease modifying anti-rheumatic drug therapy in early rheumatoid arthritis, Arthritis Rheum, 2002, vol. 46 (pg. 894–8).10.1002/art.10135Search in Google Scholar

10. Suarez-Almazor ME et al., Use of second line drugs for the treatment of rheumatoid arthritis in Edmonton, Alberta, Patterns of prescription and long term effectiveness. J Rheumatol, 1995, vol. 22 (pg. 836–43).Search in Google Scholar

11. Angelo Gaffo et. al., American Journal of Health-System Pharmacy December 2006, 63 (24) 2451–2465; available at: https://doi.org/10.2146/ajhp050514.10.2146/ajhp050514Open DOISearch in Google Scholar

12. Statistical review of the population on 30.06.2015 and 31.12.2015 by gender and age, distributed by municipalities and statistical regions, NTES 3-2007, Republic of Macedonia, State statistical office; available at: http://www.stat.gov.mk/Publikacii/2.4.16.10.pdf.Search in Google Scholar

13. Y. P. M. Goekoop-Ruiterman et al., Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis, A randomized, controlled trial 2005, available at: https://doi.org/10.1002/art.21405.10.1002/art.21405Open DOISearch in Google Scholar

14. Gabay C. et all., Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial. May 201310.1016/S0140-6736(13)60250-0Search in Google Scholar

15. Summary of the product characteristics, available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000955/WC500054890.pdf.Search in Google Scholar

16. Analysis on labour force in the Republic of Macedonia conducted by department of statistics MK, available at: http://www.stat.gov.mk/PrikaziPoslednaPublikacija.aspx?id=3.Search in Google Scholar